Form 8-K - Current report:
SEC Accession No. 0000950170-25-040260
Filing Date
2025-03-17
Accepted
2025-03-17 16:13:09
Documents
11
Period of Report
2025-03-14
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K ubx-20250314.htm   iXBRL 8-K 46026
  Complete submission text file 0000950170-25-040260.txt   158895

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ubx-20250314.xsd EX-101.SCH 25006
13 EXTRACTED XBRL INSTANCE DOCUMENT ubx-20250314_htm.xml XML 4539
Mailing Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-1192
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

EIN.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38470 | Film No.: 25744560
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)